Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01880333
Other study ID # MADRE
Secondary ID
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date November 2012
Est. completion date March 2014

Study information

Verified date January 2019
Source Lady Hardinge Medical College
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The modified Atkins diet is a non-pharmacologic therapy for intractable childhood epilepsy that was designed to be a less restrictive alternative to the traditional ketogenic diet. This diet is started on an outpatient basis without a fast, allows unlimited protein and fat, and does not restrict calories or fluids. Modified Atkins diet is of special importance in resource constraint settings with paucity of trained dieticians. However, there is paucity published data on the use of the modified Atkins diet in refractory epilepsy in young children. This study aims to evaluate the efficacy and tolerability of the modified Atkins diet in refractory epilepsy in young children.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date March 2014
Est. primary completion date March 2014
Accepts healthy volunteers No
Gender All
Age group 9 Months to 3 Years
Eligibility Inclusion Criteria:

1. Age: 9 months to 3 years.

2. Seizures persisting at least three per week for > 1 month despite the appropriate use of at least 2 Anti-epileptic drugs.

Exclusion Criteria:

1. Known or suspected inborn error of metabolism, as evidenced by: Clinical suspicion of metabolic disorder as evidenced by 2 or more of the following- a history of parental consanguinity, prior affected siblings, unexplained vomiting, intermittent worsening of symptoms, recurrent episodes of lethargy, altered sensorium, or ataxia, hepatosplenomegaly on examination And/ or 2 or more of the following biochemical abnormalities High blood ammonia (>80mmol/L), High arterial lactate (>2 mmol/L), metabolic acidosis (pH <7.2), hypoglycaemia (blood sugar <40 mg/dl), abnormal urinary aminoacidogram, presence of reducing sugars or ketones in urine, and positive results on urine neurometabolic screening tests.

2. Motivational or psychosocial issues in the family which would preclude compliance

3. Systemic illness- chronic hepatic, cardiac, renal or pulmonary disease

4. Severe acute malnutrition.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Modified Atkin Diet
Eligible children will be started on Modified Atkins diet with help of trained dietician. Carbohydrates intake will be restricted to 5 grams/ day in children<18 mo and 10grams/day in children 18mo- 3 years.Carbohydrate values of various food items will be explained in detail. Fats (e.g. cream, butter, oils, and ghee) will be encouraged. Proteins (cheese, fish, eggs, chicken, and soya products) will be unrestricted. Calcium and multivitamin supplementation will be done. Syrups will be restricted. Clear carbohydrates free fluids- will not be restricted. Medications will be changed to carbohydrate free preparations, wherever available. Diary of events will be recorded including seizure frequency and any adverse or positive effect. Urine ketones chart will be maintained.

Locations

Country Name City State
India Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital New Delhi Delhi

Sponsors (1)

Lead Sponsor Collaborator
Lady Hardinge Medical College

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Other Proportion of children with seizure freedom at 3 months 3 months
Other Percentage of children discontinuing diet before 3 months as per parenteral reports 3 months
Primary Proportion of children with > 50% seizure reduction at 3 months After 3 months of diet initiation
Secondary Frequency of adverse effects of the modified Atkins diet. 3 months
See also
  Status Clinical Trial Phase
Completed NCT02866240 - Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy N/A
Withdrawn NCT04753983 - A Study to Evaluate fMRI of Active DBS Stimulation in Epilepsy N/A
Completed NCT01899898 - Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy Phase 2/Phase 3
Recruiting NCT05493722 - Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy Early Phase 1
Recruiting NCT03062514 - Trial to Evaluate the Safety and Effectiveness of Vagus Nerve Stimulation for Children With Refractory Epilepsy N/A
Recruiting NCT04770337 - Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy N/A
Recruiting NCT05232630 - Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes Phase 4
Completed NCT04545346 - The Potential of a Low Glutamate Diet as a Treatment for Pediatric Epilepsy N/A
Not yet recruiting NCT04542629 - Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children Phase 4
Terminated NCT03570489 - Randomized Controlled Trial on Cardiovascular Exercise in Uncontrolled Epilepsy: N/A
Completed NCT05031208 - Acute and Long Term Effects of VNS on Memory in Patients With Refractory Epilepsy N/A
Completed NCT03676569 - Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy Phase 1
Withdrawn NCT03115489 - Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus Phase 2/Phase 3
Completed NCT02876289 - Retrospective Evaluation of Perampanel in a French Neurology and Epileptology Department (Hospices Civil de Lyon) N/A
Completed NCT01521754 - Product Surveillance Registry- Deep Brain Stimulation for Epilepsy
Recruiting NCT04684797 - Localization of the Reward Positivity to ACC N/A
Completed NCT05292183 - Modulation of Emotion Perception in Humans Via Amygdala Stimulation N/A
Terminated NCT04398667 - European Non-interventional Study on Refractory Epilepsy With Developmental Delay
Active, not recruiting NCT04218812 - Clinical Utility of Automated Electric Source Imaging in Presurgical Evaluation N/A
Terminated NCT02474407 - Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®) Phase 2